Strange Bedfellows in the Pharma Lobby
It isn’t PhDs in the white lab coats who show up at your doctor’s office to provide false or misleading information about drug safety.
Read MoreSelect Page
Posted by C. Scott McMillin | Feb 26, 2018 | Public Policy | 1 |
It isn’t PhDs in the white lab coats who show up at your doctor’s office to provide false or misleading information about drug safety.
Read MorePosted by C. Scott McMillin | Feb 22, 2018 | Addictive Substances, Thinking About Addiction | 0 |
We may be stuck relying on the soft stuff– therapy, support, behavior change, even spiritual growth– all those icky-squicky things that neuroscientists struggle to quantify.
Read MorePosted by C. Scott McMillin | Feb 19, 2018 | In the News, Prevention, Public Policy | 0 |
…if this type of strategy didn’t succeed 30 years ago, what makes us think it’ll be a success this time around?
Read MorePosted by C. Scott McMillin | Feb 15, 2018 | Public Policy, Treatment | 0 |
When they get sick with diseases related to substance use, they’ll avoid going to the doctor or hospital, until their illness is advanced and more extensive and expensive care is involved.
Read MorePosted by C. Scott McMillin | Feb 12, 2018 | In the News | 2 |
It’s the result of a problem in medicine that’s been going on since before I ever started working in the field. The drugs have changed, but the results haven’t.
Read More